

浏览全部资源
扫码关注微信
上海中医药大学 附属曙光医院,国家中医药管理局 中药制剂三级实验室,上海 201203
Received:22 April 2024,
Accepted:08 July 2024,
Published Online:10 July 2024,
Published:05 March 2025
移动端阅览
张建伟,华杰凯,李荣胜等.基于UPLC-Q-Orbitrap-MS分析芪苈强心胶囊的物质基础及其体内分布[J].中国实验方剂学杂志,2025,31(05):185-193.
ZHANG Jianwei,HUA Jiekai,LI Rongsheng,et al.Material Basis and Its Distribution in vivo of Qili Qiangxin Capsules Analyzed by UPLC-Q-Orbitrap-MS[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(05):185-193.
张建伟,华杰凯,李荣胜等.基于UPLC-Q-Orbitrap-MS分析芪苈强心胶囊的物质基础及其体内分布[J].中国实验方剂学杂志,2025,31(05):185-193. DOI: 10.13422/j.cnki.syfjx.20250263.
ZHANG Jianwei,HUA Jiekai,LI Rongsheng,et al.Material Basis and Its Distribution in vivo of Qili Qiangxin Capsules Analyzed by UPLC-Q-Orbitrap-MS[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(05):185-193. DOI: 10.13422/j.cnki.syfjx.20250263.
目的
2
基于超高效液相色谱-四极杆-静电场轨道阱高分辨质谱法(UPLC-Q-Orbitrap-MS),定性分析芪苈强心胶囊中的化学成分及其体内分布。
方法
2
采用UPLC-Q-Orbitrap-MS对芪苈强心胶囊供试品溶液、灌胃给药后小鼠的血清及脑、心脏、肺脏、脾脏、肝脏、肾脏中的化学成分进行检测,通过Thermo Xcalibur 2.2软件构建化合物信息数据库,并拟合准分子离子对应的化合物分子式,以保留时间、精确相对分子质量、碎片离子等信息,结合对照品和文献数据,鉴定芪苈强心胶囊中化学成分及其体内分布情况。
结果
2
从芪苈强心胶囊中共鉴定或推测出233种化合物,包括萜类70种、黄酮类60种、有机酸类23种、生物碱类17种、甾类20种、香豆素类7种、其他类36种,其中73种化合物通过对照品鉴定。组织分布结果显示,分别在血、脑、心脏、肺脏、脾脏、肝脏及肾脏中检测到移行成分71、17、38、33、32、58、43种。奎宁酸、苯甲酰新乌头原碱、苯甲酰乌头原碱等37种化学成分移行入血和心脏;毛蕊异黄酮、美迪紫檀烷、芒柄花素、泽泻醇B和泽泻醇A等14种化学成分在血和各组织中均有分布。
结论
2
该研究较全面地分析芪苈强心胶囊的物质基础及其体内分布情况,其中黄芪甲苷、丹酚酸B、人参皂苷Rb
1
、人参皂苷Rb
3
、人参皂苷Rd、人参皂苷Rg
3
、毛蕊异黄酮苷和芥子碱等成分可能是治疗心力衰竭的重要成分,可为芪苈强心胶囊的质量控制和药效物质基础研究提供依据。
Objective
2
Based on ultra-performance liquid chromatography-quadrupole-electrostatic field orbitrap high resolution mass spectrometry(UPLC-Q-Orbitrap-MS), the chemical constituents of Qili Qiangxin capsules was identified, and their distribution
in vivo
was analyzed.
Methods
2
UPLC-Q-Orbitrap-MS was used to detect the sample solution of Qili Qiangxin capsules, as well as the serum, brain, heart, lung, spleen, liver and kidney tissues of mice after oral administration. Using the Thermo Xcalibur 2.2 software, the compound information database was constructed, and the molecular formulas of compounds corresponding to the quasi-molecular ions were fitted. Based on the information of retention time, accurate relative molecular mass and fragments, the compounds and their distribution
in vivo
were analyzed by comparing with the data of reference substances and literature.
Results
2
A total of 233 compounds, including 70 terpenoids, 60 flavonoids, 23 organic acids, 17 alkaloids, 20 steroids, 7 coumarins and 36 others, were identified or predicted from Qili Qiangxin capsules, 73 of which were identified matching with standard substances. Tissue distribution results showed that 71, 17, 38, 33, 32, 58 and 43 migrating components were detected in blood, brain, heart, lung, spleen, liver and kidney, respectively. Thirty-seven components were absorbed into the blood and heart, including quinic acid, benzoylaconitine benzoylmesaconine and so on. Fourteen components were absorbed into the blood and six tissues, including calycosin, methylnissolin, formononetin, alisol B, alisol A and so on.
Conclusion
2
This study comprehensively analyzes the chemical components of Qili Qiangxin capsules and their distribution
in vivo
. Among them, astragaloside Ⅳ, salvianolic acid B, ginsenoside Rb
1
, ginsenoside Rb
3
, ginsenoside Rd, ginsenoside Rg
3
, calycosin-7-glucoside, and sinapine may be the important components for the treatment of heart failure, which can provide useful reference for its quality control and research on pharmacodynamic material basis.
国家药典委员会 . 中华人民共和国药典:一部 [M]. 北京 : 中国医药科技出版社 , 2020 : 335-336,982-984 .
Chinese Pharmacopoeia Commission . Pharmacopoeia of the People's Republic of China:Volume 1 [M]. Beijing : Chinese Medical Science Press , 2020 : 335-336,982-984 .
骆睿翔 , 张晨 , 吴旸 , 等 . 基于网络药理学与分子对接探讨芪苈强心胶囊治疗慢性心力衰竭的作用机制 [J]. 中西医结合心脑血管病杂志 , 2022 , 20 ( 12 ): 2113 - 2124 .
LUO R X , ZHANG C , WU Y , et al . The mechanism of Qiliqiangxing capsule in treatment of chronic heart failure based on network pharmacology and molecule docking [J]. Chin J Integr Med Cardio/Cerebrocasc Dis , 2022 , 20 ( 12 ): 2113 - 2124 .
FU J , CHANG L , HARMS A C , et al . A metabolomics study of Qiliqiangxin in a rat model of heart failure:A reverse pharmacology approach [J]. Sci Rep , 2018 , 8 ( 1 ): 3688 .
ZHANG J , WEI C , WANG H , et al . Protective effect of qiliqiangxin capsule on energy metabolism and myocardial mitochondria in pressure overload heart failure rats [J]. Evid Based Complement Alternat Med , 2013 , 2013 : 378298 .
HAN A , LU Y , ZHENG Q , et al . Qiliqiangxin attenuates cardiac remodeling via inhibition of TGF- β 1 /Smad3 and NF- κ B signaling pathways in a rat model of myocardial infarction [J]. Cell Physiol Biochem , 2018 , 45 ( 5 ): 1797 - 1806 .
ZHAO Q , LI H , CHANG L , et al . Qiliqiangxin attenuates oxidative stress-induced mitochondrion-dependent apoptosis in cardiomyocytes via PI3K/Akt/GSK3 β signaling pathway [J]. Biol Pharm Bull , 2019 , 42 ( 8 ): 1310 - 1321 .
WANG Y , FU M , WANG J , et al . Qiliqiangxin improves cardiac function through regulating energy metabolism via HIF-1 α -dependent and independent mechanisms in heart failure rats after acute myocardial infarction [J]. Biomed Res Int , 2020 : 1276195 .
ZHOU J , JIANG K , DING X , et al . Qiliqiangxin inhibits angiotensin Ⅱ-induced transdifferentiation of rat cardiac fibroblasts through suppressing interleukin-6 [J]. J Cell Mol Med , 2015 , 19 ( 5 ): 1114 - 1121 .
高曼 , 李欢欢 , 杨晓燕 . 芪苈强心胶囊联合沙库巴曲缬沙坦钠片治疗扩张型心肌病的效果及对心室重构的影响 [J]. 临床医学研究与实践 , 2023 , 8 ( 35 ): 125 - 128,153 .
GAO M , LI H H , YANG X Y . Effect of Qili Qiangxin capsules combined with sacubitril-valsartan sodium tablets in the treatment of dilated cardiomyopathy and its influence on ventricular remodeling [J]. Clin Res Pract , 2023 , 8 ( 35 ): 125 - 128,153 .
ZHANG F , ZHANG Y , LI X , et al . Research on Q-markers of Qiliqiangxin capsule for chronic heart failure treatment based on pharmacokinetics and pharmacodynamics association [J]. Phytomedicine , 2018 , 44 : 220 - 230 .
乔莉 , 贾继明 , 王宗权 , 等 . 使用UPLC/Q-TOF-MS/MS快速鉴定芪苈强心胶囊有效部位中的二萜类生物碱 [J]. 中草药 , 2013 , 44 ( 24 ): 3452 - 3456 .
QIAO L , JIA J M , WANG Z Q , et al . Rapid identification of diterpenoid alkaloids in active fraction of Qili Qiangxin capsule by UPLC/Q-TOF-MS/MS [J]. Chin Tradit Herb Drugs , 2013 , 44 ( 24 ): 3452 - 3456 .
张瑜 , 张富赓 , 朱明丹 , 等 . 芪苈强心胶囊中酚酸类成分在大鼠体内药动学研究 [J]. 天津中医药 , 2019 , 36 ( 8 ): 808 - 813 .
ZHANG Y , ZHANG F G , ZHU M D , et al . Pharmacokinetic study of phenolic acids in rat plasma after oral administration of Qili Qiangxin capsule [J]. Tianjin J Tradit Chin Med , 2019 , 36 ( 8 ): 808 - 813 .
张瑜 , 张富赓 , 张博凯 , 等 . 芪苈强心胶囊中黄芪甲苷、毛蕊异黄酮葡萄糖苷和芒柄花素在大鼠体内药动学研究 [J]. 中草药 , 2019 , 50 ( 16 ): 3891 - 3896 .
ZHANG Y , ZHANG F G , ZHANG B K , et al . Pharmacokinetics study of astragaloside,calycosin-7-glucoside and formononetin of Qili Qiangxin capsule in rats [J]. Chin Tradit Herb Drugs , 2019 , 50 ( 16 ): 3891 - 3896 .
康利平 , 赵阳 , 余河水 , 等 . 采用UPLC-Q-TOF/MS E 鉴别芪苈强心胶囊有效部位中的化学成分 [J]. 药学学报 , 2011 , 46 ( 10 ): 1231 - 1236 .
KANG L P , ZHAO Y , YU H S , et al . Identification of chemical constituents in Qiliqiangxin capsule by UPLC-Q-TOF/MS E [J]. Acta Pharm Sin , 2011 , 46 ( 10 ): 1231 - 1236 .
朱慧明 . 基于液质联用技术的芪苈强心胶囊中多组分分析与药代动力学研究 [D]. 石家庄 : 河北医科大学 . 2014 .
ZHU H M . Multicomponent analysis and pharmacokinetic studies by UPLC/Q-TOF-MS/MS in Qiliqiangxin capsules [D]. Shijiazhuang : Hebei Medical University . 2014 .
张建伟 , 刘伟 , 沈沁 , 等 . 基于UPLC-Q-Orbitrap-MS的鹿角方化学成分及组织分布分析 [J]. 中国实验方剂学杂志 , 2024 , 30 ( 8 ): 148 - 156 .
ZHANG J W , LIU W , SHEN Q , et al . Analysis of chemical components and tissue distribution of Lujiao formula based on UPLC-Q-Orbitrap MS [J]. Chin J Exp Tradit Med Form , 2024 , 30 ( 8 ): 148 - 156 .
张瑜 , 张富赓 , 朱明丹 , 等 . 芪苈强心胶囊中生物碱在大鼠体内的药动学行为 [J]. 中成药 , 2019 , 41 ( 8 ): 1757 - 1762 .
ZHANG Y , ZHANG F G , ZHU M D , et al . In vivo pharmacokinetic behaviors of alkaloids in Qili Qiangxin capsules in rats [J]. Chin Tradit Pat Med , 2019 , 41 ( 8 ): 1757 - 1762 .
弓建红 . 南葶苈子的化学成分研究 [D]. 哈尔滨 : 黑龙江中医药大学 , 2016 .
GONG J H . Chemical constttuents from the seeds of Deseurainia sophia [D]. Harbin : Heilongjiang University of Chinese Medicine , 2016 .
单晓晓 , 洪帮振 , 刘洁 , 等 . 丹参化学成分、药理作用、临床应用的研究进展及质量标志物的预测分析 [J]. 中国中药杂志 , 2021 , 46 ( 21 ): 5496 - 5511 .
SHAN X X , HONG B Z , LIU J , et al . Review of chemical composition,pharmacological effects,and clinical application of Salviae Miltiorrhizae Radix et Rhizoma and prediction of its Q-markers [J]. China J Chin Mater Med , 2021 , 46 ( 21 ): 5496 - 5511 .
杨宇 , 黄兴琳 , 江忠敏 , 等 . 中药红花化学成分与药理作用研究新进展 [J]. 中华中医药学刊 , 2023 , 41 ( 10 ): 119 - 126 .
YANG Y , HUANG X L , JIANG Z M , et al . New research progress for chemical compositions and pharmacological effect of Honghua(Carthami Flos) [J]. Chin Arch Tradit Chin Med , 2023 , 41 ( 10 ): 119 - 126 .
赵淑秀 , 郭娜 , 刘琦 , 等 . 香加皮化学成分信息库的构建 [J]. 中药材 , 2023 , 46 ( 4 ): 1043 - 1053 .
ZHAO S X , GUO N , LIU Q , et al . Construction of the chemical constituents information database of Periploca sepium Bge .[J]. J Chin Med Mater , 2023 , 46 ( 4 ): 1043 - 1053 .
宋书祎 , 兰先明 , 徐静 , 等 . 附子二萜类生物碱UHPLC-Q-Exactive Orbitrap MS的系统分析鉴定 [J]. 药物分析杂志 , 2023 , 43 ( 6 ): 918 - 929 .
SONG S Y , LAN X M , XU J , et al . Systematic analysis and identification of diterpenoid alkaloids from Aconitum carmichaeli Debx. by UHPLC-Q-Exactive Orbitrap MS [J]. Chin J Pharm Anal , 2023 , 43 ( 6 ): 918 - 929 .
黄亚威 , 周慧娟 , 刘旭云 , 等 . 不同品种红花HPLC指纹图谱及其化学成分差异性研究 [J]. 中成药 , 2023 , 45 ( 1 ): 155 - 160 .
HUANG Y W , ZHOU H J , LIU X Y , et al . HPLC fingerprints and chemical constituent differences for Carthamus tinctorius from different cultivars [J]. Chin Tradit Pat Med , 2023 , 45 ( 1 ): 155 - 160 .
蔡芷辰 , 李振麟 , 徐谦 , 等 . 桂枝的化学成分分析 [J]. 中国实验方剂学杂志 , 2014 , 20 ( 22 ): 57 - 60 .
CAI Z C , LI Z L , XU Q , et al . Chemical contituents from ramulus of Cinnamomum cassia [J]. Chin J Exp Tradit Med Form , 2014 , 20 ( 22 ): 57 - 60 .
扈晓佳 , 殷莎 , 袁婷婷 , 等 . 红花的化学成分及其药理活性研究进展 [J]. 药学实践杂志 , 2013 , 31 ( 3 ): 161 - 168,197 .
HU X L , YIN S , YUAN T T , et al . Chemical constituents and pharmacological activities of Carthamus tinctorius L. [J]. J Pharm Prac Serv , 2013 , 31 ( 3 ): 161 - 168,197 .
姚鹏 , 李洋 , 杜昆泽 , 等 . UPLC同时测定香加皮中六种成分 [J]. 中国现代中药 , 2019 , 21 ( 10 ): 1377 - 1381,1396 .
YAO P , LI Y , DU K Z , et al . Simultaneous determination of six components in Periplocae Cortex by UPLC [J]. Mod Chin Med , 2019 , 21 ( 10 ): 1377 - 1381,1396 .
孙崇德 , 陈昆松 , 戚行江 , 等 . 柑桔果实柠檬苦素类化合物的研究与应用 [J]. 浙江农业学报 , 2002 , 14 ( 5 ): 51 - 56 .
SUN C D , CHEN K S , QIN X J , et al . Studies and utilizations on limonoids from citrus frutis [J]. Acta Agric Zhejiang , 2002 , 14 ( 5 ): 51 - 56 .
陈嘉慧 , 张雅心 , 刘孟华 , 等 . 基于UPLC-Q-TOF-MS/MS技术的丹参水提液全成分分析 [J]. 广东药科大学学报 , 2020 , 36 ( 1 ): 1 - 9 .
CHEN J H , ZHANG Y X , LIU M H , et al . Chemical profiling of Danshen water extract by UPLC-Q-TOF-MS/MS [J]. J Guangdong Pharm Univ , 2020 , 36 ( 1 ): 1 - 9 .
张清 , 李荣胜 , 黄思红 , 等 . 基于UHPLC-Q-Exactive Orbitrap HRMS技术分析黄芪汤颗粒的化学成分与小鼠口服后的入血成分 [J]. 上海中医药杂志 , 2023 , 57 ( 9 ): 70 - 77 .
ZHANG Q , LI R S , HUANG S H , et al . Chemical profiling of Huangqi decoction granules and characterization of absorbed components and metabolites in mice plasma following oral administration based on UHPLC⁃Q⁃Exactive Orbitrap HRMS [J]. Shanghai J Tradit Chin Med , 2023 , 57 ( 9 ): 70 - 77 .
陈婷 , 田丰 , 唐跃年 , 等 . HPLC-ESI-TOF/MS对黄芪药材中24种化学成分的快速分离与鉴别 [J]. 中国药师 , 2014 , 17 ( 4 ): 593 - 596 .
CHEN T , TIAN F , TANG Y N , et al . Quick separation and identification of 24 chemical constituents in Radix Astragali by HPLC-ESI-TOF/MS [J]. China Pharm , 2014 , 17 ( 4 ): 593 - 596 .
王芦笛 , 杨维 , 李鹰飞 , 等 . 香加皮的化学成分及主要毒性研究进展 [J]. 国际药学研究杂志 , 2016 , 43 ( 6 ): 1067 - 1075 .
WANG L D , YANG W , LI Y F , et al . Chemical constituents of Cortex Periplocae Radicis and its main toxic ingredients:Research advances [J]. J Int Pharm Res , 2016 , 43 ( 6 ): 1067 - 1075 .
戴梦翔 , 金姝娜 , 宋成武 , 等 . 泽泻及其炮制品化学成分和药理作用的研究进展 [J]. 中草药 , 2023 , 54 ( 5 ): 1620 - 1635 .
DAI M X , JIN S N , SONG C W , et al . Research progress on chemical constituents and pharmacological effects of Alisma Rhizoma and its processed products [J]. Chin Tradit Herb Drugs , 2023 , 54 ( 5 ): 1620 - 1635 .
HE W , LI Y , QIN Y , et al . New cryptotanshinone derivatives with anti-influenza a virus activities obtained via biotransformation by Mucor rouxii [J]. Appl Microbiol Biotechnol , 2017 , 101 ( 16 ): 6365 – 6374 .
王红 , 崔议方 , 姜慧祯 , 等 . 基于UHPLC-Q-Exactive Orbitrap MS技术分析不同干燥方法对人参皂苷类成分的影响 [J]. 中国中药杂志 , 2022 , 47 ( 19 ): 5246 - 5255 .
WANG H , CUI Y F , JIANG H Z , et al . Effects of different drying methods on ginsenosides based on UHPLC-Q-Exactive Orbitrap MS technique [J]. China J Chin Mater Med , 2022 , 47 ( 19 ): 5246 - 5255 .
LIANG C , YAO Y , DING H , et al . Rapid classification and identification of chemical components of Astragali Radix by UPLC-Q-TOF-MS [J]. Phytochem Anal , 2022 , 33 ( 6 ): 943 - 960 .
石婧婧 , 陈舒妤 , 邹立思 , 等 . 超快速液相色谱-三重四级杆-线性离子阱质谱法分析人参和红参中皂苷类成分 [J]. 中国药学杂志 , 2018 , 53 ( 22 ): 1944 - 1951 .
SHI J J , CHEN S Y , ZOU L S , et al . Comparative analysis of Ginsenosides in Ginseng Radix et Rhizoma and Ginseng Radix et Rhizoma Rubra by UFLC-QTRAP-MS/MS [J]. Chin Pharm J , 2018 , 53 ( 22 ): 1944 - 1951 .
王静 , 姚长良 , 张建青 , 等 . 基于UPLC-Q-TOF-MS的人参配方颗粒化学成分及指纹图谱研究 [J]. 中草药 , 2022 , 53 ( 11 ): 3286 - 3294 .
WANG J , YAO C L , ZHANG J Q , et al . Study on chemical components and chromatographic fingerprints of ginseng dispensing granules based on UPLC-Q-TOF-MS [J]. Chin Tradit Herb Drugs , 2022 , 53 ( 11 ): 3286 - 3294 .
EDTA . 人参 [DB/OL].[ 2024-02-05 ]. http://www.tcmip.cn/ETCM/index.php/Home/Index/yc_details.html?id=265 http://www.tcmip.cn/ETCM/index.php/Home/Index/yc_details.html?id=265 .
EDTA . Ren Shen [DB/OL].[ 2024-02-05 ]. http://www.tcmip.cn/ETCM/index.php/Home/Index/yc_details.html?id=265 http://www.tcmip.cn/ETCM/index.php/Home/Index/yc_details.html?id=265 .
TCMSP . 人参 [DB/OL].[ 2024-02-05 ]. https://old.tcmsp-e.com/tcmspsearch.php?qr=Ginseng%20Folium&qsr=herb_ en_name&token=4265c71f3c53cd1e4a9f683ca241512c https://old.tcmsp-e.com/tcmspsearch.php?qr=Ginseng%20Folium&qsr=herb_en_name&token=4265c71f3c53cd1e4a9f683ca241512c .
TCMSP . Renshen [DB/OL].[ 2024-02-05 ]. https://old.tcmsp-e.com/tcmspsearch.php?qr=Ginseng%20Folium&qsr=herb_ en_name&token=4265c71f3c53cd1e4a9f683ca241512c https://old.tcmsp-e.com/tcmspsearch.php?qr=Ginseng%20Folium&qsr=herb_en_name&token=4265c71f3c53cd1e4a9f683ca241512c .
LI X , ZHANG J , HUANG J , et al . A multicenter,randomized,double-blind,parallel-group,placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure [J]. J Am Coll Cardiol , 2013 , 62 ( 12 ): 1065 - 1072 .
LIANG T , ZHANG Y , YIN S , et al . Cardio-protecteffect of qiliqiangxin capsule on left ventricular remodeling,dysfunction and apoptosis in heart failure rats after chronic myocardial infarction [J]. Am J Transl Res , 2016 , 8 ( 5 ): 2047 - 2058 .
SUI Y B , WANG Y , LIU L , et al . Astragaloside Ⅳ alleviates heart failure by promoting angiogenesis through the JAK-STAT3 pathway [J]. Pharm Biol , 2019 , 57 ( 1 ): 48 - 54 .
CHAI C J , SUN Y , CHI R F , et al . Astragaloside Ⅳ alleviates LPS-induced cardiomyocyte hypertrophy and collagen expression associated with CCL2-mediated activation of NF- κ B signaling pathway [J]. Biochem Biophys Res Commun , 2024 , 693 : 149367 .
ZHANG T , WANG H , LU M , et al . Astragaloside Ⅳ prevents myocardial hypertrophy induced by mechanical stress by activating autophagy and reducing inflammation [J]. Am J Transl Res , 2020 , 12 ( 9 ): 5332 - 5342 .
LIU Z H , LIU H B , WANG J . Astragaloside Ⅳ protects against the pathological cardiac hypertrophy in mice [J]. Biomed Pharmacother , 2018 , 97 : 1468 - 1478 .
MAO Q , SHAO C , ZHOU H , et al . Exploring the mechanism of salvianolic acid B against myocardial ischemia-reperfusion injury based on network pharmacology [J]. Pharmaceuticals (Basel) , 2024 , 17 ( 3 ): 309 .
LI C , ZHANG X , LI J , et al . Ginsenoside Rb 1 promotes the activation of PPAR α pathway via inhibiting FADD to ameliorate heart failure [J]. Eur J Pharmacol , 2023 , 947 : 175676 .
KONG H L , HOU A J , LIU N N , et al . The effects of ginsenoside Rb 1 on fatty acid β -oxidation,mediated by AMPK,in the failing heart [J]. Iran J Basic Med Sci , 2018 , 21 ( 7 ): 731 - 737 .
CHEN X , WANG Q , SHAO M , et al . Ginsenoside Rb 3 regulates energy metabolism and apoptosis in cardiomyocytes via activating PPAR α pathway [J]. Biomed Pharmacother , 2019 , 120 : 109487 .
ZHANG N , AN X , LANG P , et al . Ginsenoside Rd contributes the attenuation of cardiac hypertrophy in vivo and in vitro [J]. Biomed Pharmacother , 2019 , 109 : 1016 - 1023 .
李虎峰 , 李科 , 吕弯弯 , 等 . 仿野生黄芪与移栽黄芪的糖谱差异分析 [J]. 中国实验方剂学杂志 , 2023 , 29 ( 20 ): 141 - 148 .
LI H F,LI K,LYU W W,Analysis on sugar spectrum difference between wild-simulated and transplanted Astragali Radix [J]. Chin J Exp Tradit Med Form , 2023 , 29 ( 20 ): 141 - 148 .
李红蓉 , 张世雄 , 李雅文 , 等 . 人参抗衰老研究进展 [J]. 中国实验方剂学杂志 , 2024 , 30 ( 3 ): 196 - 207 .
LI H R , ZHANG S X , LI Y W , et al . Anti-aging effect of Ginseng Radix et Rhizoma:A review [J]. Chin J Exp Tradit Med Form , 2024 , 30 ( 3 ): 196 - 207 .
0
Views
166
下载量
1
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621